Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels
Keiran S.M. Smalley(Moffitt Cancer Center), Meenhard Herlyn(The Wistar Institute)
Cited by 105
Related Papers
A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas
|Cancer Research|2005|1.3k
PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
|Cancer Research|2011|546
Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
|British Journal of Cancer|2010|313
Human Melanoma Progression in Skin Reconstructs
|American Journal Of Pathology|2000|236
Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells
|The Journal of Immunology|2001|231